Stockreport

Auris Medical Announces Positive Results From Second Phase 1 Clinical Trial With Intranasal Betahistine

Auris Medical Holding AG  (EARS) 
Last auris medical holding ag earnings: 8/10 06:31 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aurismedical.com
PDF Bioavailability significantly higher than with oral administration Treatment safe and multiple dosing well tolerated Company to move forward with planned proof-of-c [Read more]